Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. [electronic resource]
Producer: 19990218Description: 715-21 p. digitalISSN:- 1078-0432
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- pathology
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Hematopoiesis
- Hematopoietic Stem Cell Transplantation
- Humans
- Leukapheresis
- Leukocyte Count
- Lymphatic Metastasis
- Middle Aged
- Neoplasm Staging
- Platelet Count
- Recombinant Proteins
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.